Skip to main content
. 2015 Jan 6;23(4):341–351. doi: 10.1016/j.jsps.2014.08.004

Figure 5.

Figure 5

(A) Pictographic representation of the clonogenic assay UC: untreated control, A: pure Cisplatin, B: Cisplatin albumin nanoparticles, C: blank albumin nanoparticles, 1: IC20 concentration, 2: IC50 concentration and (B) comparative evaluation of the reduction in the number of colonies for the treatment groups in comparison with control (P < 0.001).